Internal Medicine, Infectious Disease · Fresno, CA
NPI
1154380343
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7035 N Maple Ave, Suit-101
Fresno, CA, 93720
Phone (559) 323-4987
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,043 services
Medicare patients, 2024
830
Average age 74
Drug cost, 2024
$1.7M
2,091 prescriptions
Company payments, 2025
$1,910
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pushpalatha V Arakere was code 99233 (hospital e&m - subsequent), 619 times for 339 patients. In total Pushpalatha V Arakere billed 2,043 services in 13 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 619 | 339 | $84.05 | $52K |
| 99223 Hospital E&M - Initial | Facility | 567 | 517 | $122.78 | $70K |
| 99214 Office E&M - Established | Office | 364 | 200 | $90.53 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 160 | 85 | $56.16 | $8,986 |
| 99204 Office E&M - New | Office | 139 | 139 | $114.64 | $16K |
| 99291 Critical Care E&M | Facility | 104 | 40 | $149.96 | $16K |
| 99213 Office E&M - Established | Office | 51 | 40 | $57.17 | $2,916 |
By year: 2022 $215K for 1,979 services; 2023 $252K for 2,358 services; 2024 $200K for 2,043 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pushpalatha V Arakere prescribed most often to Medicare patients was Doxycycline Hyclate, with 208 prescriptions and refills. In total Pushpalatha V Arakere wrote 2,091 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 208 | 379 | 72 | $8,512 |
| Cephalexin Generic | 173 | 340 | 48 | $2,511 |
| Methenamine Hippurate Generic | 131 | 215 | 32 | $9,346 |
| Fluconazole Generic | 115 | 204 | 42 | $14K |
| Azithromycin Generic | 109 | 210 | 38 | $2,023 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 96 | 137 | 54 | $4,221 |
| Ethambutol Hcl Generic | 89 | 151 | 28 | $3,135 |
| Rifampin Generic | 77 | 121 | 26 | $2,309 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 48 | 48 | Under 11 | $201K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 48 | 93 | 18 | $552 |
| Ceftriaxone Ceftriaxone Sodium | 42 | 42 | 12 | $7,867 |
| Estradiol Generic | 38 | 86 | 20 | $3,072 |
| Voriconazole Generic | 36 | 67 | Under 11 | $31K |
| Vancomycin Hcl Generic | 35 | 35 | 13 | $4,386 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 34 | 34 | Under 11 | $155K |
Brand drugs: - claims; generic drugs: 1,788 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pushpalatha V Arakere $1,910 ($1,910 in general payments such as food, travel and fees) from 14 companies. The largest payer was ViiV Healthcare Company with $518.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 23 | $518 |
| Gilead Sciences, Inc. GILD | 15 | $321 |
| Astellas Pharma US Inc 4503.T | 8 | $302 |
| Electromed, Inc. ELMD | 19 | $208 |
| Insmed, Inc. INSM | 5 | $143 |
| EMD Serono, Inc. MRK.DE | 3 | $99.41 |
| Paratek Pharmaceuticals, Inc. | 3 | $60.85 |
| Theratechnologies Inc. THTX | 2 | $57.24 |
| La Jolla Pharmaceutical Company | 2 | $54.01 |
| Philips North America LLC PHG | 2 | $51.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.